Furthermore, some DT CAR-T designs co-targeting MSLN and NKG2D ligands induce the secretion of bispecific T-cell engagers (BiTEs) that recruit endogenous T cells and natural killer (NK) cells into the tumor site, amplifying immune infiltration even in immunologically “cold” TNBC models [34]. Here, MSLN is linked to neoplasm.